High Pain Intervention in Cesarean Sections
CompletedNot applicableNCT01298778
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
In previous studies the investigators have seen that the severity of pain one day after cesarean delivery can predict the presence of pain and depression 2 months later. The investigators believe those at risk for severe acute post-partum pain can be identified, and medical interventions can be tailored to manage postoperative pain more effectively.
Study details
- Official title
- Improving Pain Relief For Those Who Need It Most After Cesarean Delivery
- Conditions
- Other Chronic Postoperative Pain
- Interventions
- Drug: Duramorph 150
- Drug: Acetaminophen
- Drug: Duramorph 300
- Sponsor
- Wake Forest University Health Sciences
- Start date
- 2010-08
- Primary completion
- 2011-07
- Sex
- Female
- Age range
- from 18 Years to 45 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * elective cesarean section * age \>/= 18 years old * not allergic proposed study medications * predicted to experience high pain postop based on preoperative evaluation Exclusion Criteria: * allergy to study medications * known hepatic disease * weight \> 300 lbs
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT01298778